Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Stevens

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
The Journal of Biological Chemistry|July 18, 2021
GSK137, a potent small-molecule BCL6 inhibitor with in vivo activity, suppresses antibody responses in miceAndrew C Pearce, Mark J Bamford, Ruth Barber, et al.
ACS Medicinal Chemistry Letters|December 18, 2024
Optimization of Potent and Selective Cyclohexyl Acid ERAP1 Inhibitors Using Structure- and Property-Based Drug DesignRoss P Hryczanek, Andrew S Hackett, Paul Rowland, et al.
Journal of Medicinal Chemistry|June 22, 2026
Discovery of an Orally Available Potent ER Aminopeptidase 1 (ERAP1) Inhibitor That Enhances Antitumor Responses and Limits Inflammatory Autoimmunity <i>In Vivo</i>Christopher P Tinworth, Justyna Wojno-Picon, Michael Adam, et al.
Bioconjugate Chemistry|February 1, 2021
<i>In Vivo</i> Half-Life Extension of BMP1/TLL Metalloproteinase Inhibitors Using Small-Molecule Human Serum Albumin BindersJulien C Vantourout, Andrew M Mason, Josephine Yuen, et al.
Journal of Medicinal Chemistry|April 13, 2026
Automated Molecular Design in BRADSHAW, Applied to the Optimization of ERAP1 InhibitorsRobert P Law, Ian D Wall, Richard Lonsdale, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
The Journal of Biological Chemistry|July 18, 2021
GSK137, a potent small-molecule BCL6 inhibitor with in vivo activity, suppresses antibody responses in miceAndrew C Pearce, Mark J Bamford, Ruth Barber, et al.
ACS Medicinal Chemistry Letters|December 18, 2024
Optimization of Potent and Selective Cyclohexyl Acid ERAP1 Inhibitors Using Structure- and Property-Based Drug DesignRoss P Hryczanek, Andrew S Hackett, Paul Rowland, et al.
Journal of Medicinal Chemistry|June 22, 2026
Discovery of an Orally Available Potent ER Aminopeptidase 1 (ERAP1) Inhibitor That Enhances Antitumor Responses and Limits Inflammatory Autoimmunity <i>In Vivo</i>Christopher P Tinworth, Justyna Wojno-Picon, Michael Adam, et al.
Bioconjugate Chemistry|February 1, 2021
<i>In Vivo</i> Half-Life Extension of BMP1/TLL Metalloproteinase Inhibitors Using Small-Molecule Human Serum Albumin BindersJulien C Vantourout, Andrew M Mason, Josephine Yuen, et al.
Journal of Medicinal Chemistry|April 13, 2026
Automated Molecular Design in BRADSHAW, Applied to the Optimization of ERAP1 InhibitorsRobert P Law, Ian D Wall, Richard Lonsdale, et al.
Pageof 6